CBPO - China Biologic Products Holdings, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
536,552
503,745
466,878
370,407
341,169
Cost of revenue
192,028
174,667
146,787
125,517
124,034
Gross profit
344,524
329,078
320,090
244,890
217,135
Operating expenses
Research development
11,146
11,735
9,524
6,504
7,022
Selling general and administrative
145,591
153,696
164,393
102,528
66,198
Total operating expenses
156,738
165,430
173,918
109,031
73,220
Operating income or loss
187,786
163,648
146,173
135,859
143,915
Interest expense
598.722
557.597
338.136
583.432
254.471
Total other income/expenses net
6,296
7,081
6,462
3,509
2,443
Income before tax
212,809
191,494
166,003
146,408
153,919
Income tax expense
31,803
28,099
18,036
64,172
25,126
Income from continuing operations
181,006
163,395
147,967
82,236
128,793
Net income
154,500
138,808
128,056
67,943
104,779
Net income available to common shareholders
152,810
137,117
124,984
65,754
101,792
Basic EPS
-
3.55
3.54
2.40
3.79
Diluted EPS
-
3.53
3.53
2.38
3.74
Basic average shares
-
38,658
35,304
27,362
26,848
Diluted average shares
-
38,898
35,433
27,606
27,249
EBITDA
-
218,292
189,567
159,900
166,912